Rhodiola crenulata reduces ventricular arrhythmia through mitigating the activation of IL-17 and inhibiting the MAPK signaling pathway
ConclusionsRC inhibited the expression of IL-17 and its downstream target genes that were mediated by activation of several MAPKs, which decreased the levels of fibrosis and apoptosis and suppressed VA.
Source: Cardiovascular Drugs and Therapy - Category: Cardiology Source Type: research
More News: Arrhythmia | Biochemistry | Cardiology | Cardiovascular | Genetics | Heart | Heart Failure | Rhodiola | Study | Ventricular Arrhythmia